Exploring new treatments for kidney disease linked to primary cilia
Harnessing the potential of GPCRs localized to the primary cilium for the treatment of renal disease
This study is looking at how certain proteins in kidney cells can help manage Autosomal Dominant Polycystic Kidney Disease (ADPKD) by understanding how cysts form and cause kidney problems, which could lead to new treatments that slow down the disease and improve life for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Boston Health Care System NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11194935 on NIH RePORTER |
What this research studies
This research focuses on Autosomal Dominant Polycystic Kidney Disease (ADPKD), a condition that leads to kidney dysfunction and cyst formation. The study investigates the role of primary cilia in kidney cells and how targeting specific proteins involved in this process could help manage or treat the disease. By understanding the mechanisms behind cyst formation and kidney damage, the research aims to develop new therapeutic strategies that could slow disease progression and improve patient outcomes. Patients with ADPKD, particularly those affected by its complications, may find this research relevant to their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with Autosomal Dominant Polycystic Kidney Disease, especially those experiencing early symptoms or complications.
Not a fit: Patients without a diagnosis of ADPKD or those with other unrelated kidney diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly slow the progression of kidney disease in patients with ADPKD.
How similar studies have performed: Previous research has shown promise in targeting similar pathways in kidney diseases, indicating potential for success in this novel approach.
Where this research is happening
Boston, United States
- VA Boston Health Care System — Boston, United States (Active)
Researchers
- Principal investigator: Hofer, Aldebaran M — VA Boston Health Care System
- Study coordinator: Hofer, Aldebaran M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.